Gitnux/Report 2026

Womens Longevity Industry Statistics

The women-first longevity and wellness-concierge segment totaled an estimated $4.3 billion in 2025, explore the figures behind growth, companies and trends shaping 2026.
5Statistics
23Sources
2Sections
1Visuals
13mRead
Womens Longevity Industry Statistics
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The womens longevity industry at a glance

Women’s longevity is emerging as a distinct preventive-health category, with an estimated $4.3 billion total addressable market in 2025 spanning menopause, midlife care, hormonal health and wellness concierge services.

$4.3B[4]
Women-first longevity TAM, 2025
8–10%[5]
Menopause market CAGR, 2025–2030
1B+[4]
Peri- or post-menopausal women globally
$100M[6]
Midi Health Series D, 2026
Market size
The women-first longevity and wellness-concierge segment had an estimated global total addressable market of approximately $4.3 billion in 2025. A broader PwC estimate puts core women’s health—including menopause, fertility, maternity, gynecologic conditions and oncology—at roughly $195–205 billion in 2025.[4][5]
Forecast & CAGR
PwC forecasts the menopause market to grow at approximately 8–10% annually from 2025 to 2030, reaching about $15–25 billion by 2030 from an estimated $10–15 billion market today. Across core women’s health, PwC projects 6–8% annual growth through 2030, while consumer health technology is expected to grow 14–17% annually.[5]
Market share & regions
The available industry estimates are global, but investment and service delivery are concentrated in the United States: the World Economic Forum specifically identifies U.S. women-first longevity and wellness-concierge services, while PwC’s broader market model covers global pharmaceuticals, devices, providers, payers and consumer solutions. No reliable comparable regional market-share percentages were disclosed.[4][5]
Segmentation
The category is segmented across integrated clinical care, hormonal and metabolic management, menopause and midlife services, wellness concierge programs, diagnostics, digital health, wearables and consumer products. In the wider women’s-health market, PwC estimates 2025 spending of approximately $220–230 billion for providers and care delivery, $100–110 billion for pharma, $70–80 billion for devices and diagnostics, and $13–18 billion for consumer technology.[4][5]
Key players & concentration
Named participants include Midi Health, Hone Health, Flo and Maven, alongside newer virtual-care, diagnostics and wellness platforms. Capital is still fragmented: the World Economic Forum reports approximately $400 million raised by the women-first longevity sector between 2020 and 2025, with nearly 90% of investments coming through private funding rounds; no reliable market-share concentration ratio was disclosed.[4][7]
Trends, drivers & challenges
Demand is being driven by more than 1 billion peri- or post-menopausal women globally, increasing awareness, employer interest in midlife care and the shift toward continuous, personalized prevention. Challenges include fragmented access, limited clinician training, underdiagnosis, affordability and regulatory scrutiny of premium diagnostics and concierge services that may lack robust clinical validation.[4][5]
Consumer behavior & competition
NIQ reports that 54% of U.S. women aged 35–49 were actively seeking supplements for menopause-related symptoms in 2025, while 64% researched treatment options independently before consulting a healthcare provider. Online sales remain the dominant channel for menopause supplements, increasing competition among telehealth platforms, supplements, beauty brands, wearables and diagnostics providers.[8]
Regulation
U.S. regulation is moving alongside the market: in February 2026, the FDA approved labeling changes for six menopausal hormone-therapy products, removing certain cardiovascular-disease, breast-cancer and probable-dementia statements from boxed warnings. The FDA also approved the first generic once-weekly Climara Pro equivalent in October 2026, potentially improving access to hormone therapy.[9]
Latest news
The most significant recent financing was Midi Health’s $100 million Series D announced in February 2026, which valued the menopause and midlife virtual-care company at more than $1 billion and supported expansion across all 50 U.S. states. In October 2026, the FDA approved the first generic version of a once-weekly combined estrogen-and-progestogen menopause patch.[6][9]

02 Ranking

Top 10 Companies in the Womens Longevity Industry

The leading companies in the womens longevity industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 20, 2026 · Next review December 20, 2026

Verdict

Natural Cycles stands out for perimenopause-oriented contraceptive and cycle tracking because its FDA-cleared app includes a perimenopause mode used by more than 6 million users, while Carrot focuses on fertility-to-menopause coverage since it spans fertility, pregnancy, postpartum and menopause on a global platform.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in menopause & midlife care platforms

    Natural Cycles

    SE

    Ranked #1 · 9.4 · Menopause & midlife care platforms

    Why we picked it: It combines cycle tracking with a perimenopause mode inside an FDA-cleared contraceptive app used by more than 6 million users.

  2. Leader in women’s health diagnostics & procedures

    Hologic

    US

    Ranked #3 · 8.8 · Women’s health diagnostics & procedures

    Why we picked it: It develops diagnostics, imaging and surgical technologies targeted to women’s health across clinic and treatment workflows.

  3. Leader in women’s health pharmaceuticals

    Theramex

    GB

    Ranked #4 · 8.8 · Women’s health pharmaceuticals

    Why we picked it: It is a women’s health pharmaceutical company with a dedicated portfolio spanning menopause, contraception and osteoporosis.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the womens longevity industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Natural Cycles

Menopause & midlife care platforms · SE

9.4
2

Carrot

Menopause & midlife care platforms · US

9.2
3

Hologic

Women’s health diagnostics & procedures · US

8.8
4

Theramex

Women’s health pharmaceuticals · GB

8.8
5

Peppy

Employer menopause & care benefits · GB

8.7
6

Progyny

Fertility and family-building benefits · US

8.5
7

Elektra Health

Menopause telemedicine and midlife care · US

8.4
8

Organon

Women's health medicines and fertility products · US

8.2
9

Kindbody

Fertility clinics and family-building care · US

8.1
10

Evernow

Longitudinal menopause and healthy-aging care · US

8.0

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 20, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 10 companies in the womens longevity industry. In Womens Longevity Industry Statistics. Gitnux. https://gitnux.org/womens-longevity-industry-statistics/#top-companies

report visual · Comparison

U.S. women’s health market size

U.S. women’s health market size: $32.4B in 2022, $32.4B in 2022.

2027 (forecast)$45.4B
2026 (forecast)$43.4B
2025 (forecast)$41.3B
2024 (forecast)$38.7B
2023 (forecast)$35.5B
2022$32.4B
source-verifiedstifel.com2027

04 Statistics

Market Intelligence

Market sizing spans multiple lenses, including a $4.3B women-first longevity TAM in 2025 and BCG’s $350B incremental global opportunity estimate in 2026.

Market size and service revenue in the womens longevity industry

  • $350 billion was BCG’s estimated incremental global opportunity in 2026 for women’s longevity products and services, calculated for roughly 1 billion menopausal women already spending on longevity; category includes consumables, services and specialized treatments.[1]
  • $84 per month was the median reported longevity spending in 2026 among women undergoing perimenopause or menopause, versus $68 for other women and $73 for men; category includes consumables, services and specialized treatments.[1]

05 Statistics

People & Workforce

Certified clinical capacity is tracked through The Menopause Society credentials, with more than 2,000 U.S. certified practitioners in 2024 and more than 15,000 professionals globally in 2026.

Skills and certification in the womens longevity industry

  • More than 2,000 U.S. healthcare professionals held The Menopause Society Certified Practitioner credential, a parent-discipline qualification relevant to women’s longevity care; reference period 2024, United States.[2]
  • 106 Ohio healthcare providers held Menopause Society Certified Practitioner credentials as of January 30, 2025, indicating the certified-provider base available to women’s longevity care in Ohio.[3]
  • More than 15,000 professionals belonged to The Menopause Society, the parent professional discipline serving women’s midlife and longevity care; reference period 2026, global membership.[2]

Key questions about the womens longevity industry

What is the 2025 total addressable market for women’s longevity?
The women-first longevity TAM in 2025 is estimated at $4.3 billion, spanning menopause, midlife care, hormonal health and wellness concierge services.
How fast is the menopause market expected to grow from 2025 to 2030?
PwC forecasts menopause market growth of approximately 8–10% annually from 2025 to 2030, reaching about $15–25 billion by 2030.
Which companies lead the womens longevity industry?
Natural Cycles stands out for perimenopause-oriented contraceptive and cycle tracking because its FDA-cleared app includes a perimenopause mode used by more than 6 million users, while Carrot focuses on fertility-to-menopause coverage since it spans fertility, pregnancy, postpartum and menopause on a global platform.
Which technology and product shifts are shaping womens longevity in this period?
AI is described as becoming embedded in clinical workflows, while wearables expand beyond cycle tracking. Diagnostics face a validation reset, and regulation changes affect hormone therapy product access.
How is the market structured across care delivery, pharma, devices and consumer technology?
PwC estimates 2025 spending of about $220–230 billion for providers and care delivery, $100–110 billion for pharma, $70–80 billion for devices and diagnostics, and $13–18 billion for consumer technology.
How do spending levels differ across womens groups in 2026?
In 2026, the median reported longevity spending is $84 per month for women undergoing perimenopause or menopause, versus $68 for other women and $73 for men.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Womens Longevity Industry Statistics. Gitnux. https://gitnux.org/womens-longevity-industry-statistics
MLA
Samuel Norberg. "Womens Longevity Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/womens-longevity-industry-statistics.
Chicago
Samuel Norberg. 2026. "Womens Longevity Industry Statistics." Gitnux. https://gitnux.org/womens-longevity-industry-statistics.